Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
Conferences > BIO > 2004 > ThF > ThF9

Pharmacokinetics model to assess the extravasation of tumor tissue by using fluorescence contrast agents

Ping Huang, Xavier Intes, Shoko Nioka, and Britton Chance

Not Accessible

Your library or personal account may give you access

Abstract

The pharmacokinetics model is developed to describe the delivery of ICG injected intravenously into the human subject. The proposed model can differentiate between normal tissue and tumor with large leakiness of vasculature, and has great potential for assisting in clinical diagnosis of early breast cancer.

© 2004 Optical Society of America

PDF Article
More Like This
Pharmacokinetics of ICG and HPPH-car for Detection of Normal and Tumor Tissue Using Fluorescence, Near-Infrared Continuous Wave Imaging

Michael Gurfinkel, Alan B. Thompson, William Ralston, Tamara L. Troy, Jeffery S. Reynolds, Bruce Muggenberger, Kristin Nikula, Ravindra Pandey, Ralf Mayer, Daniel J. Hawrysz, and Eva M. Sevick-Muraca
MD7 Biomedical Optical Spectroscopy and Diagnostics (BIOMED) 2000

Pharmacokinetic Analysis for Tumor Characterization Using MR-Guided Dynamic Contrast Enhanced Diffuse Optical Tomography

Mitchell Hsing, Yuting Lin, and Gultekin Gulsen
BTu2A.3 Biomedical Optics (BIOMED) 2012

Breast tumor images of hemodynamic information Using a contrast agent with back projection and FFT enhancement

S. Nioka, SB. Colak, X. Li, Y. Yang, and B. Chance
ATuD8 Advances in Optical Imaging and Photon Migration (BIOMED) 1998

View More...
Select as filters
Select Topics Cancel
Top
       
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Privacy | Terms of Use